Andrew Scharenberg
Vorstandsvorsitzender bei Umoja Biopharma, Inc.
Profil
Andrew Scharenberg is the founder of Generation Bio Co. (founded in 2017).
Dr. Scharenberg is also the founder of Umoja Biopharma, Inc. Dr. Scharenberg's current job is as an Executive Partner at MPM BioImpact, Inc. (since 2019).
Dr. Scharenberg's former jobs include being an Advisor at bluebird bio, Inc. (2014-2017), Chief Scientific Officer at Cellectis, Inc. (2011-2014), and Chief Scientific Officer at Casebia Therapeutics LLC (2017-2019).
Dr. Scharenberg graduated from UNC School of Medicine with a graduate degree in 1993.
Aktive Positionen von Andrew Scharenberg
| Unternehmen | Position | Beginn |
|---|---|---|
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Vorstandsvorsitzender | - |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.06.2019 |
Ehemalige bekannte Positionen von Andrew Scharenberg
| Unternehmen | Position | Ende |
|---|---|---|
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01.08.2019 |
| BLUEBIRD BIO, INC. | Berater | 01.06.2017 |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Corporate Officer/Principal | 30.06.2014 |
| GENERATION BIO CO. | Gründer | - |
Ausbildung von Andrew Scharenberg
| UNC School of Medicine | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| GENERATION BIO CO. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Health Technology |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
